Trials / Not Yet Recruiting
Not Yet RecruitingNCT06757985
Doppler Echocardiography Versus Clinical Targets Guided Therapy on the Outcome of Postpartum Septic Shock.
Doppler Echocardiography Versus Clinical Targets Guided Therapy on the Outcome of Postpartum Septic Shock, a Randomized Controlled Trial
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Assiut University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
Postpartum sepsis is widely known as a preventable main cause of maternal morbidity and mortality. According to the World Health Organization, approximately 11% of the estimated maternal deaths worldwide were attributed to sepsis. Recent global assessments indicate that obstetric infections rank as the third most prevalent cause of maternal death, with a prevalence mainly observed in low- and middle-income nations.
Detailed description
The management of septic shock is a major medical concern. Early goal-directed therapy emerged as a novel approach for reducing sepsis mortality and was incorporated into Surviving Sepsis Campaign guidelines in 2012. Early detection of sepsis, rapid initiation of antibiotics and effective resuscitation with fluids, vasopressors, and inotropes were important concerns. However, many randomized trials were done to examine the effect of EGDT on morbidity and mortality and showed that EGDT was not associated with a significant reduction in mortality in patients with septic shock compared to usual care. That it wasn't addressed in recent guidelines in 2016 and 2021.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | a clinically guided resuscitation protocol, | a clinically guided resuscitation protocol, derived from EGDT and modified to match with the latest survival sepsis campaign guidelines |
| PROCEDURE | a transthoracic bedside focused echocardiographic assessment | a transthoracic bedside focused echocardiographic assessment of the patient will be done, as a baseline ECHO in a three-step approach to monitor hemodynamics using Logiq P7, S5-1 ECHO probe; |
Timeline
- Start date
- 2024-12-30
- Primary completion
- 2026-11-01
- Completion
- 2026-11-30
- First posted
- 2025-01-03
- Last updated
- 2025-01-06
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06757985. Inclusion in this directory is not an endorsement.